EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
2.4.1.192 | (25R)-5alpha-spirostan-3beta-ol + UDP-glucose |
i.e. tigogenin, at 12% of the activity with nuatigenin |
Avena sativa |
UDP + (25R)-5alpha-spirostan-3beta-ol 3-O-beta-D-glucoside |
- |
? |
2.4.1.192 | (25R)-5alpha-spirostane-3beta,6alpha-diol + UDP-glucose |
i.e. chlorogenin, at 30% of the activity with nuatigenin |
Avena sativa |
UDP + (25R)-5alpha-spirostane-3beta,6alpha-diol 3-O-beta-D-glucoside |
- |
? |
2.4.1.192 | (25R)-spirost-5-en-3beta-ol + UDP-glucose |
- |
Avena sativa |
UDP + (25R)-spirost-5-en-3beta-ol 3-O-beta-D-glucoside |
- |
? |
2.4.1.192 | (25R)-spirost-5-en-3beta-ol + UDP-glucose |
i.e. diosgenin, at 17% of the activity with nuatigenin |
Avena sativa |
UDP + (25R)-spirost-5-en-3beta-ol 3-O-beta-D-glucoside |
- |
? |
2.4.1.192 | 20S,22S,25S-spirost-5-ene-3beta,25-diol + UDP-glucose |
- |
Avena sativa |
UDP + 20S,22S,25S-spirost-5-ene-3beta,25-diol 3-O-beta-D-glucoside |
- |
? |
2.4.1.192 | 20S,22S,25S-spirost-5-ene-3beta,25-diol + UDP-glucose |
i.e. isonuatigenin, at 57% of the activity with nuatigenin |
Avena sativa |
UDP + 20S,22S,25S-spirost-5-ene-3beta,25-diol 3-O-beta-D-glucoside |
- |
? |
2.4.1.192 | 22S,25S-5alpha-tomatanin-3beta-ol + UDP-glucose |
i.e. tomatidine, at 57% of the activity with nuatigenin |
Avena sativa |
UDP + 22S,25S-5alpha-tomatanin-3beta-ol 3-O-beta-D-glucoside |
- |
? |
2.4.1.192 | 22S,25S-solanid-5-enin-3beta-ol + UDP-glucose |
i.e. solanidine, at 39% of the activity with nuatigenin |
Avena sativa |
UDP + gamma-chaconine |
- |
? |
2.4.1.192 | androst-5-en-3beta-ol-17-one + UDP-glucose |
i.e. androsterone, at 15% of the activity with nuatigenin |
Avena sativa |
UDP + androst-5-en-3beta-ol-17-one 3-O-beta-D-glucoside |
- |
? |
2.4.1.192 | pregn-5-en-3beta-ol-20-one + UDP-glucose |
i.e. pregnenolone, at 26% of the activity with nuatigenin |
Avena sativa |
UDP + pregn-5-en-3beta-ol-20-one 3-O-beta-D-glucoside |
- |
? |